GBS Inc. (NYSE:GBS – Get Free Report) dropped 2.1% during trading on Wednesday . The stock traded as low as $1.88 and last traded at $1.89. Approximately 27,914 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 955,325 shares. The stock had previously closed at $1.93.
GBS Trading Down 2.1 %
The company has a market capitalization of $28.14 million, a P/E ratio of -3.38 and a beta of 1.32. The firm has a fifty day moving average of $2.49 and a 200 day moving average of $2.51.
GBS Company Profile
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Featured Stories
- Five stocks we like better than GBS
- 3 REITs to Buy and Hold for the Long Term
- Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
- Investing In Preferred Stock vs. Common Stock
- Campbell Soup Co. Targets Fiscal Q4 Stock Recovery
- What is a Death Cross in Stocks?
- Zebra Analysts Upgrade Stock, Forecasting Major Reversal
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
